MedTrace Logo

Probiotic for Vaginal Candidiasis in Pregnant Women

NCT03940612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-28

No results posted yet for this study

Summary

This project aims to study the benefits of a probiotic product, STP4 for vaginal health properties, primarily prevention of vaginal candidiasis, among pregnant women in second and third trimester pregnancy.

Conditions

  • Vaginal Diseases

Interventions

DIETARY_SUPPLEMENT

STP4 (product with probiotics)

STP4 contains Lactobacillus plantarum LP115, Lactobacillus helveticus LA25, Lactobacillus rhamnosus LRH10, Lactobacillus paracasei LPC12, Lactobacillus fermentum LF26, Lactobacillus delbrueckii subsp. lactis, LDL114. Administration at 10 log CFU/day for 8-weeks.

DIETARY_SUPPLEMENT

Placebo (product without probiotics)

Capsules are similar to STP4 except the presence of probiotics. Administration daily for 8-weeks.

Sponsors & Collaborators

  • SYNBIO TECH INC. Kaohsiung Taiwan

    collaborator UNKNOWN

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Fadlina Adnan, MD · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-16
Primary Completion
2020-10-03
Completion
2020-10-03

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940612 on ClinicalTrials.gov